Simple, direct drug susceptibility testing technique for diagnosis of drug-resistant tuberculosis in resource-poor settings

被引:3
作者
Kim, C-K. [1 ]
Joo, Y-T. [1 ]
Lee, E. P. [1 ]
Park, Y. K. [1 ]
Kim, H-J. [1 ]
Kim, S. J. [1 ]
机构
[1] Korean Inst TB, Korean Natl TB Assoc, Seoul, South Korea
关键词
Kudoh-modified Ogawa medium; MDR-TB; XDR-TB; programmatic management of drug-resistant TB; MYCOBACTERIA; SENSITIVITY;
D O I
10.5588/ijtld.12.1009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
SETTING: The Korean Institute of Tuberculosis, Seoul, Republic of Korea. OBJECTIVE: To develop a simple, direct drug susceptibility testing (DST) technique using Kudoh-modified Ogawa (KMO) medium. DESIGN: The critical concentrations of isoniazid (INH), rifampicin (RMP), kanamycin (KM) and ofloxacin (OFX) for KMO medium were calibrated by comparing the minimal inhibitory concentrations (MICs) against clinical isolates of Mycobacterium tuberculosis on KMO with those on Lowenstein-Jensen (q). The performance of the direct KMO DST technique was evaluated on 186 smear-positive sputum specimens and compared with indirect LJ DST. RESULTS: Agreement of MICs on direct vs. indirect DST was high for INH, RMP and OFX. KM MICs on KMO were 10 mu g/ml higher than those on LJ. The critical concentrations of INH, RAP, OFX and KM for KMO were therefore set at 0.2, 40.0, 2.0, and 40.0 mu g/ml. The evaluation of direct DST of smear-positive sputum specimens showed 100% agreement with indirect LJ DST for INH and RMP. However, the respective susceptible and resistant predictive values were 98.8% and 100% for OFX, and 100% and 80% for KM. CONCLUSION: Direct DST using KMO is useful, with clear advantages of a shorter turnaround time, procedural simplicity and low cost compared to indirect DST. It may be most indicated in resource-poor settings for programmatic management of drug-resistant tuberculosis.
引用
收藏
页码:1212 / 1216
页数:5
相关论文
共 16 条
  • [1] Isolation of Mycobacterium tuberculosis Strains with a Silent Mutation in rpoB Leading to Potential Misassignment of Resistance Category
    Alonso, Maria
    Jose Palacios, Juan
    Herranz, Marta
    Penedo, Ana
    Menendez, Angela
    Bouza, Emilio
    Garcia de Viedma, Dario
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (07) : 2688 - 2690
  • [2] Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
    Boehme, Catharina C.
    Nabeta, Pamela
    Hillemann, Doris
    Nicol, Mark P.
    Shenai, Shubhada
    Krapp, Fiorella
    Allen, Jenny
    Tahirli, Rasim
    Blakemore, Robert
    Rustomjee, Roxana
    Milovic, Ana
    Jones, Martin
    O'Brien, Sean M.
    Persing, David H.
    Ruesch-Gerdes, Sabine
    Gotuzzo, Eduardo
    Rodrigues, Camilla
    Alland, David
    Perkins, Mark D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11) : 1005 - 1015
  • [3] CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565
  • [4] CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
  • [5] Meta-analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without solid media, for detection of mycobacteria
    Cruciani, M
    Scarparo, C
    Malena, M
    Bosco, O
    Serpelloni, G
    Mengoli, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (05) : 2321 - 2325
  • [6] Kam KM, 2010, INT J TUBERC LUNG D, V14, P282
  • [7] Drug-susceptibility testing in tuberculosis: Methods and reliability of results
    Kim, SJ
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 25 (03) : 564 - 569
  • [8] KUDOH S, 1974, B WORLD HEALTH ORGAN, V51, P71
  • [9] Evaluation of the Cepheid Xpert MTB/RIF Assay for Direct Detection of Mycobacterium tuberculosis Complex in Respiratory Specimens
    Marlowe, Elizabeth M.
    Novak-Weekley, Susan M.
    Cumpio, Joven
    Sharp, Susan E.
    Momeny, Michelle A.
    Babst, Anna
    Carlson, Jonathan S.
    Kawamura, Masae
    Pandori, Mark
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (04) : 1621 - 1623
  • [10] Petrie A, 2000, MED STAT GLANCE, P138